Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study

Gastroenterology

Volumn 148, Issue 7, 2015, Pages 1340-1352.e7

  Chalasani, Naga ^a   Bonkovsky, Herbert L ^b   Fontana, Robert ^c   Lee, William ^d   Stolz, Andrew ^e   Talwalkar, Jayant ^f   Reddy, K Rajendar ^g   Watkins, Paul B ^h   Navarro, Victor ⁱ   Barnhart, Huiman ^j   Gu, Jiezhun ^j   Serrano, Jose ^k   Ahmad, Jawad ^l   Bach, Nancy ^l   Bansal, Meena ^l   Barnhart, Huiman X ^l   Beavers, Kimberly ^l   Calvo, Francisco O ^l   Chang, Charissa ^l   Conjeevaram, Hari ^l   Conner, Gregory ^l   Darling, Jama ^l   De Boer, Ynto ^l   Dieterich, Douglas ^l   Dipaola, Frank ^l   Durazo, Francisco A ^l   Everhart, James E ^l   Fontana, Robert J ^l   Ghabril, Marwan S ^l   Goldstein, David ^l   Gopalreddy, Vani ^l   Grewal, Priya ^l   Hayashi, Paul H ^l   Hoofnagle, Jay ^l   Kaplowitz, Neil ^l   Liangpunsakul, Suthat ^l   Lichtman, Steven ^l   Liu, Lawrence ^l   Navarro, Victor J ^l   Odin, Joseph ^l   Rossi, Simona ^l   Russo, Mark ^l   Schiano, Thomas ^l   Sherker, Averell H ^l   Vuppalanchi, Raj ^l   Zacks, Steven ^l   Balasco, Amanda ^l   Chesney, Kristin ^l   Corne, Audrey ^l   Cummings, Sherrie ^l   Groseclose, Gale ^l   Hammett, Alex ^l   Hooker, Judy ^l   Kesar, Varun ^l   Mao, Sophana ^l   Marks, Kenari ^l   McFadden, Regina ^l   Melgoza, Yolanda ^l   Mikhail, Sherif ^l   Milstein, Susan ^l   Morlan, Wendy ^l   Peacock, Val ^l   Rosado, Nidia ^l   Russell, Tracy ^l   Vega, Maricruz ^l   Verma, Manisha ^l   Walker, Patricia ^l   Yalamanchili, Rachana ^l   McClanahan Crowder, Michelle ^l   Galan, Katherine ^l   Chau, Tuan ^l   Ragavan, Kowsalya ^l   Rostami, Hoss ^l   Puglisi Scharenbroich, Carmel ^l   Torrance, Rebecca J ^l   Van Raaphorst, Rebekah ^l   more..

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Levine Cancer Institute   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f MAYO CLINIC   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h UNIVERSITY OF NORTH CAROLINA   (United States)

ⁱ EINSTEIN MEDICAL CENTER   (United States)

^j DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^k NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^l NONE

more..

Author keywords

DILI; DILIN; Idiosyncratic; Medication; Toxicity

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZATHIOPRINE; AZITHROMYCIN; CARBAMAZEPINE; CEFACLOR; CEFALEXIN; CEFAZOLIN; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DALTEPARIN; DICLOFENAC; DIGESTIVE TRACT AGENT; ERYTHROMYCIN; FLUCONAZOLE; HERBACEOUS AGENT; ISONIAZID; LAMOTRIGINE; LEVOFLOXACIN; MINOCYCLINE; MOXIFLOXACIN; NITROFURANTOIN; RIFAMPICIN; STEROID; THYMOCYTE ANTIBODY; UNINDEXED DRUG;

ADULT; AGED; ARTICLE; CHILD; CHOLESTASIS; CLINICAL FEATURE; DISEASE SEVERITY; FEMALE; HUMAN; LIVER DISEASE; LIVER INJURY; LIVER TRANSPLANTATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; STEROID THERAPY; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TOXIC HEPATITIS; YOUNG ADULT; AGE; COMORBIDITY; COMPARATIVE STUDY; DRUG ERUPTIONS; DRUG-INDUCED LIVER INJURY; DRUG-INDUCED LIVER INJURY, CHRONIC; PROGNOSIS; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME; UNITED STATES;

ADULT; AGE FACTORS; AGED; COMORBIDITY; DRUG ERUPTIONS; DRUG-INDUCED LIVER INJURY; DRUG-INDUCED LIVER INJURY, CHRONIC; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; UNITED STATES;

EID: 84930017409     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.03.006     Document Type: Article

References (33)

1. N.P. Chalasani, P.H. Hayashi, and H.L. Bonkovsky The Diagnosis and management of idiosyncratic drug induced liver injury Am J Gastroenterol 109 2014 950 956
2. R.J. Andrade, M.I. Lucena, and M.C. Fernandez Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period Gastroenterology 129 2005 512 521
3. H.L. Bonkovsky, S.I. Shedlofsky, and D.P. Jones Drug-induced liver injury T.D. Boyer, M.P. Manns, A. Sanyal, Zakim and Boyer's Hepatology - A Textbook of Liver Disease 6th ed. 2010 Saunders-Elsevier Philadelphia 417 461
4. C. Sgro, F. Clinard, and K. Ouazir Incidence of drug-induced hepatic injuries: a French population-based study Hepatology 36 2002 451 455
5. E. Bjornsson, O.M. Bergmann, and H.K. Bjornsson Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland Gastroenterology 144 2013 1419 1425
6. A. Reuben, D.G. Koch, and W.M. Lee Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a US multicenter, prospective study Hepatology 52 2010 2065 2076
7. W.M. Lee Drug-induced acute liver failure Clin Liver Dis 17 2013 575 586
8. A. Regev How to avoid being surprised by hepatotoxicity at the final stages of drug development and approval Clin Liver Dis 17 2013 749 767
9. Drug-Induced Livery Injury Network. What is DILN. Available at: https://dilin.dcri.duke.edu/. Accessed August 20, 2014.
10. R.J. Fontana, P.B. Watkins, H.L. Bonkovsky DILIN Study Group Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct Drug Saf 32 2009 55 68
11. N. Chalasani, R.J. Fontana, and H.L. Bonkovsky Causes, clinical features, and outcomes from a prospective study of drug induced liver injury in the United States Gastroenterology 135 2008 1924 1934
12. T.J. Davern, N. Chalasani, and R.J. Fontana Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury Gastroenterology 141 2011 1665 1672 e1-e9
13. N. Chalasani, R. Vuppalanchi, and V.J. Navarro Acute liver injury due to Flavocoxid (limbrel), a medical food for osteoarthritis. A case series Ann Intern Med 156 2013 857 860
14. D.E. Kleiner, N. Chalasani, and W. Lee Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations Hepatology 59 2014 661 670
15. R.J. Fontana, P.H. Hayashi, and J. Gu There is substantial morbidity and mortality associated with idiosyncratic drug induced liver injury: results from the DILIN Prospective Study Gastroenterology 147 2014 96 108
16. G. Danan, and C. Benichou Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meeting J Clin Epidemiol 46 1993 1323 1330
17. C. Benichou, G. Danan, and A. Flahault Causality assessment of adverse reactions to drugs-II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge J Clin Epidemiol 46 1993 1331 1336
18. V. Navarro, H. Barnhart, and H.L. Bonkovsky Liver injury due to herbal and dietary supplements in the US Drug-Induced Liver Injury Network Hepatology 2014 July 12 (Epub ahead of print)
19. E.M. Tan, T.E. Feltkamp, and J.S. Smolen Range of antinuclear antibodies in "healthy" individuals Arthritis Rheum 40 1997 1601 1611
20. J.P. Molleston, J. Lopez, R.J. Fontana, N. Chalasani for the Drug Induced Liver Injury Network Characteristics of drug induced liver injury in children: interim results from the DILIN Prospective Study J Pedia Gastro Hepatol 53 2011 182 189
21. M. Ghabril, R. Fontana, and D. Rockey Drug induced liver injury caused by intravenously administered medications: The Drug Induced Liver Injury Network (DILIN) experience J Clinical Gastroenterology 47 2013 553 558
22. R. Vuppalanchi, P. Hayashi, N. Chalasani the Drug Induced Liver Injury Network Duloxetine hepatotoxicity: a case-series from the Drug-Induced Liver Injury Network (DILIN) Aliment Pharmacol Ther 32 2010 1174 1183
23. R.J. Fontana, P. Hayashi, and H.L. Bonkovsky Presentation and outcomes with interferon beta hepatotoxicity Dig Dis Sci 58 2013 1766 1775
24. E.S. Orman, H.S. Conjeevaram, and R. Vuppalanchi Clinical and histologic features of fluoroquinolone-induced liver injury Clin Gastroenterol Hepatol 9 2011 517 523
25. M.I. Lucena, R.J. Andrade, and M.C. Fernandez Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain Hepatology 44 2006 850 856
26. M. Black, J.R. Mitchell, and H.J. Zimmerman Isoniazid-associated hepatitis in 114 patients Gastroenterology 69 1975 289 302
27. S.K. Sharma, A. Balamurugan, and P.K. Saha Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment Am J Respir Crit Care Med 166 2002 916 919
28. B.H. Stricker, A.P. Blok, and F.H. Claas Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases Hepatology 8 1988 599 606
29. M.I. Lucena, R.J. Andrade, and N. Kaplowitz Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex Hepatology 49 2009 2001 2009
30. H. Devarbhavi, D. Karanth, and K.S. Prasanna Drug induced liver injury with hypersensitivity features has a better outcome: a single center experience of 39 children and adolescents Hepatology 54 2011 1344 1350
31. R.A. Schwartz, P.H. McDonough, and B.W. Lee Toxic epidermal necrolysis: Part 1. Introduction, history, classification, etiology, and immunopathogenesis J Am Acad Dermatol 69 2013 173 e1-e13
32. R.A. Schwartz, P.H. McDonough, and B.W. Lee Toxic epidermal necrolysis: Part 2. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment J Am Acad Dermatol 69 2013 E1 E16
33. R. Vuppalanchi, and N. Chalasani Risk factors for drug induced liver injury N. Kaplowitz, L. DeLeve, Drug induced liver disease 3rd ed. 2012 Marcel Dekker New York